McDermott advised TreeFrog Therapeutics on its Collaboration with GAIA BioMedicine for the Expansion of Allogeneic NK-like cells Against Solid Tumors

McDermott Will & Emery has advised TreeFrog Therapeutics, a French-based biotech company aiming to unlock access to cell therapies for millions of patients, on its collaboration with GAIA BioMedicine for the expansion of healthy donor-derived « Natural Killer » (NK)-like cells.

The McDermott team that advised TreeFrog Therapeutics consisted of Emmanuelle Trombe, partner, and Edouard Becker, associate.